Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Characterizing longitudinal blood pressure trajectories in patients at high risk for de novo postpartum hypertension: A randomized controlled trial secondary analysis

Emeruwa UN, Sarker MR, Bello N, Jacobs M, Laurent LC, Teal EN, Wen T, Miller RS, Gyamfi-Bannerman C. Characterizing longitudinal blood pressure trajectories in patients[...]

Intracerebral Hemorrhage Outcomes After Reversal of Subtherapeutic Warfarin: Analysis of Data From GWTG-Stroke

LacKamp AN, Weber JM, Mac Grory BC, Caye AJ, Stenuf C, Smith EE, Daniels JD, Barkley TT, Messe SR, Alhanti B, Sheth KN, Blanco RG,[...]

SPARC: The Standardised Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Analysis and Reporting Consensus: A Delphi Analysis

Herrmann K, Walz J, MacLennan S, Briganti A, Cornford P, Czernin J, Eiber M, Fanti S, Fendler WP, Fizazi K, Gafita A, Gillessen S, Goffin[...]